Immunopathogenesis of schistosomiasis.
Wynn TA, Thompson RW, Cheever AW, Mentink-Kane MM.
Immunol Rev. 2004 Oct;201:156-67. doi: 10.1111/j.0105-2896.2004.00176.x.
Host Regulators of Liver Fibrosis During Human Schistosomiasis.
Kamdem SD, Moyou-Somo R, Brombacher F, Nono JK.
Front Immunol. 2018 Nov 28;9:2781. doi: 10.3389/fimmu.2018.02781. eCollection 2018.
Liver stiffness is able to differentiate hepatosplenic Schistosomiasis mansoni from liver cirrhosis and spleen stiffness may be a predictor of variceal bleeding in hepatosplenic schistosomiasis.
Silva CF, Nardelli MJ, Barbosa FA, Galizzi HO, Cal TCMF, Ferrari TCA, Faria LC, Couto CA.
Trans R Soc Trop Med Hyg. 2022 Jan 19;116(1):26-33. doi: 10.1093/trstmh/trab041.
Immunopathology of schistosomiasis.
Wilson MS, Mentink-Kane MM, Pesce JT, Ramalingam TR, Thompson R, Wynn TA.
Immunol Cell Biol. 2007 Feb-Mar;85(2):148-54. doi: 10.1038/sj.icb.7100014. Epub 2006 Dec 12.
Is cirrhosis of the liver reversible?
Kumar M, Sarin SK.
Indian J Pediatr. 2007 Apr;74(4):393-9. doi: 10.1007/s12098-007-0067-1.
The relevance of schistosomiasis.
Warren KS.
N Engl J Med. 1980 Jul 24;303(4):203-6. doi: 10.1056/NEJM198007243030408.
Pathology and molecular mechanisms of Schistosoma japonicum-associated liver fibrosis.
Liu Z, Zhang L, Liang Y, Lu L.
Front Cell Infect Microbiol. 2022 Oct 28;12:1035765. doi: 10.3389/fcimb.2022.1035765. eCollection 2022.
Involvement of SIRT1 in amelioration of schistosomiasis-induced hepatic fibrosis by genistein.
Zhou C, Li D, Ding C, Yuan Q, Yu S, Du D, Huang W, Wang D.
Acta Trop. 2021 Aug;220:105961. doi: 10.1016/j.actatropica.2021.105961. Epub 2021 May 16.
On the reversal of liver cirrhosis: mystery or reality?
Grizzi F.
Clin Exp Pharmacol Physiol. 2012 May;39(5):401-3. doi: 10.1111/j.1440-1681.2012.05698.x.
Pathogenesis of liver cirrhosis in schistosomiasis.
SYMMERS D.
J Am Med Assoc. 1951 Sep 22;147(4):304-5. doi: 10.1001/jama.1951.03670210016005.
